Order Article Reprints

Patutina O, Sen’kova A, Miroshnichenko S, Awad M, Markov O, Gladkikh D, Savin I, Seroklinova E, Zhukov S, Kupryushkin M, et al. Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer. Pharmaceutics. 2026; 18(1):122. https://doi.org/10.3390/pharmaceutics18010122

Patutina, Olga, Aleksandra Sen’kova, Svetlana Miroshnichenko, Mona Awad, Oleg Markov, Daniil Gladkikh, Innokenty Savin, Ekaterina Seroklinova, Sergey Zhukov, Maxim Kupryushkin, and et al. 2026. "Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer" Pharmaceutics 18, no. 1: 122. https://doi.org/10.3390/pharmaceutics18010122

Patutina, O., Sen’kova, A., Miroshnichenko, S., Awad, M., Markov, O., Gladkikh, D., Savin, I., Seroklinova, E., Zhukov, S., Kupryushkin, M., Maslov, M., Vlassov, V., & Zenkova, M. (2026). Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer. Pharmaceutics, 18(1), 122. https://doi.org/10.3390/pharmaceutics18010122